ARCHIVES

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 15 | April 15, 2005

Download PDF Visit The Full Archive

Related Articles

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

Solomon Garb’s Questions/Answers

December 19, 1980

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

In Brief: Leonidas Platanias named director of Lurie Comprehensive Cancer Center

October 3, 2014

ONS Votes to Push Congress on DRGs

June 1, 1984